EE04176B1 - Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks - Google Patents

Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks

Info

Publication number
EE04176B1
EE04176B1 EE9700068A EE9700068A EE04176B1 EE 04176 B1 EE04176 B1 EE 04176B1 EE 9700068 A EE9700068 A EE 9700068A EE 9700068 A EE9700068 A EE 9700068A EE 04176 B1 EE04176 B1 EE 04176B1
Authority
EE
Estonia
Prior art keywords
selegiline
pct
medicament
manufacture
treatment
Prior art date
Application number
EE9700068A
Other languages
English (en)
Estonian (et)
Other versions
EE9700068A (et
Inventor
L�scher Wolfgang
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of EE9700068A publication Critical patent/EE9700068A/xx
Publication of EE04176B1 publication Critical patent/EE04176B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EE9700068A 1994-08-11 1995-07-27 Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks EE04176B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4428444A DE4428444A1 (de) 1994-08-11 1994-08-11 Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
PCT/DE1995/000981 WO1996004897A1 (de) 1994-08-11 1995-07-27 Verwendung von selegilin zur behandlung von epileptischen erkrankungen

Publications (2)

Publication Number Publication Date
EE9700068A EE9700068A (et) 1997-10-15
EE04176B1 true EE04176B1 (et) 2003-12-15

Family

ID=6525440

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700068A EE04176B1 (et) 1994-08-11 1995-07-27 Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks

Country Status (23)

Country Link
US (1) US5952388A (cs)
EP (1) EP0774961B1 (cs)
JP (1) JP3922307B2 (cs)
CN (1) CN1081918C (cs)
AT (1) ATE239458T1 (cs)
AU (1) AU691316B2 (cs)
BR (1) BR9508531A (cs)
CA (1) CA2197176C (cs)
CZ (1) CZ285681B6 (cs)
DE (2) DE4428444A1 (cs)
DK (1) DK0774961T3 (cs)
EE (1) EE04176B1 (cs)
ES (1) ES2199252T3 (cs)
HU (1) HU223529B1 (cs)
MY (1) MY116362A (cs)
NO (1) NO314684B1 (cs)
PL (1) PL188040B1 (cs)
PT (1) PT774961E (cs)
RU (1) RU2155584C2 (cs)
SK (1) SK283205B6 (cs)
TR (1) TR199500984A2 (cs)
TW (1) TW448044B (cs)
WO (1) WO1996004897A1 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
DE19743323C2 (de) * 1997-09-30 2000-05-25 Iip Inst Fuer Ind Pharmazie Fo Feste Arzneimittelzusammensetzung auf der Grundlage von Selegilin
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US20030087814A1 (en) 2001-11-05 2003-05-08 Seth Lederman Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
GB201715919D0 (en) * 2017-09-29 2017-11-15 Gw Res Ltd use of cannabinoids in the treatment of epilepsy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868218A (en) * 1987-08-18 1989-09-19 Buyske Donald A Method of treating depression
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2107552C (en) * 1991-04-04 2001-08-28 William G. Tatton Use of deprenyl to maintain, prevent loss, or recover nerve cell function
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
WO1992021333A2 (en) * 1991-05-24 1992-12-10 Pharmavene, Inc. Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
US5648087A (en) * 1993-03-09 1997-07-15 Sanofi Sante Nutrition Animale Anaesthetic pharmaceutical composition comprising a general anaesthetic and selegiline
US5462740A (en) * 1993-09-17 1995-10-31 Athena Neurosciences, Inc. Rectally-administered, epileptic-seizure-inhibiting composition

Also Published As

Publication number Publication date
BR9508531A (pt) 1998-12-01
DE59510674D1 (de) 2003-06-12
US5952388A (en) 1999-09-14
DE4428444A1 (de) 1996-02-15
WO1996004897A1 (de) 1996-02-22
PL188040B1 (pl) 2004-11-30
AU2976095A (en) 1996-03-07
NO970607D0 (no) 1997-02-10
CN1155241A (zh) 1997-07-23
CN1081918C (zh) 2002-04-03
HU223529B1 (hu) 2004-08-30
NO970607L (no) 1997-02-10
MY116362A (en) 2004-01-31
EP0774961A1 (de) 1997-05-28
PT774961E (pt) 2003-09-30
EE9700068A (et) 1997-10-15
TR199500984A2 (tr) 1996-06-21
PL318292A1 (en) 1997-06-09
CZ40797A3 (en) 1997-07-16
EP0774961B1 (de) 2003-05-07
SK283205B6 (sk) 2003-03-04
TW448044B (en) 2001-08-01
JPH10504029A (ja) 1998-04-14
CA2197176C (en) 2007-06-26
CZ285681B6 (cs) 1999-10-13
RU2155584C2 (ru) 2000-09-10
JP3922307B2 (ja) 2007-05-30
DK0774961T3 (da) 2003-09-01
SK19997A3 (en) 1997-08-06
AU691316B2 (en) 1998-05-14
NO314684B1 (no) 2003-05-05
CA2197176A1 (en) 1996-02-22
ES2199252T3 (es) 2004-02-16
ATE239458T1 (de) 2003-05-15
MX9701031A (es) 1998-05-31
HUT77175A (hu) 1998-03-02

Similar Documents

Publication Publication Date Title
PT777483E (pt) Metodos e meio para administrar farmacos
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
NO963239L (no) Klorpyrimid-mellomprodukter
EA200300503A1 (ru) Новые лекарственные композиции на основе солей тиотропия и солей салметерола
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE69827149D1 (de) Agmatin für die behandlung neuropathischer schmerzen
EE200200107A (et) Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
EE04176B1 (et) Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks
BR0108261A (pt) Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono
PT983300E (pt) Sais peptidicos de bpc com actividade organo-protectora, processo para a sua preparacao e sua utilizacao em terapia
ES2173977T3 (es) Uso de r-(z)-alfa-(metoxiimino)-alfa-(1-azabiciclo(2.2.2)oct-3-il)acetonitrilo para reducir la formacion de la proteina amilacea beta a4 en la enfermedad de alzheimer.
UY26990A1 (es) Nuevas composiciones de medicamentos
DE69627298D1 (de) Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
BR0315917A (pt) Utilização do sal distrÈnico do ácido 2-[n,n-di(carboximetil)amino]-3-ciano-4-carboximetil-ti ofeno-5-carboxìlico para a obtenção de medicamentos destinados ao tratamento das dores gastroduodenais
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs
DK0707477T3 (da) Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo
MY124089A (en) Use of cetirizine for preventing the onset of asthma
DK1007047T3 (da) Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling
ES2093515T3 (es) Aplicacion del riluzol como radio-restaurador.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

HE1A Change of address
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20080727